Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 02, 2026 Filed Jun 4, 2026 20:34 UTC |
McGowan LindseyVP, Chf. Comp. & Quality Offc.
|
Tax withholdingOrdinary Shares | 329 | $209.76 | $69,011.04 |
DisclosureSEC source: 0001628280-26-040845 · wk-form4_1780605257.xml · nonDerivative · entry 2 McGowan Lindsey · CIK 0002102487 · VP, Chf. Comp. & Quality Offc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,656 F2 · shares: 329 shares were withheld from the 1,128 restricted shares that vested on June 2, 2026. These 329 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026. F1 · balance_after: As of June 2, 2026, 3,117 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 588 on June 4, 2027; 576 on June 3, 2028; 798 on January 2, 2029 and 1,155 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:34 UTC |
McGowan LindseyVP, Chf. Comp. & Quality Offc.
|
GrantOrdinary Shares | 1,155 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040845 · wk-form4_1780605257.xml · nonDerivative · entry 1 McGowan Lindsey · CIK 0002102487 · VP, Chf. Comp. & Quality Offc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,985 F1 · balance_after: As of June 2, 2026, 3,117 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 588 on June 4, 2027; 576 on June 3, 2028; 798 on January 2, 2029 and 1,155 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:33 UTC |
Majors Cary LSVP and President, Healthcare
|
GrantEmployee Stock Option (right to buy) · Derivative | 16,548 | $0.00 Strike: $230.74 | $0.00 |
DisclosureSEC source: 0001628280-26-040843 · wk-form4_1780605234.xml · derivative · entry 4 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,548 Underlying: Ordinary Shares · 16,548 shares Expires 2036-06-02 F4 · derivative.exercise_date: This option becomes exercisable as follows: 4,137 on June 2, 2027, 4,137 on June 2, 2028, 4,137 on June 4, 2029 and 4,137 on June 3, 2030. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:33 UTC |
Majors Cary LSVP and President, Healthcare
|
Tax withholdingOrdinary Shares | 67 | $209.76 | $14,053.92 |
DisclosureSEC source: 0001628280-26-040843 · wk-form4_1780605234.xml · nonDerivative · entry 2 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,338 F2 · shares: 67 shares were withheld from the 2,140 restricted shares that vested on June 2, 2026. These 67 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026. F1 · balance_after: As of June 2, 2026, 10,047 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,379 on June 4, 2027; 2,922 on June 5, 2028 and 4,746 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:33 UTC |
Majors Cary LSVP and President, Healthcare
|
GrantOrdinary Shares | 4,746 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040843 · wk-form4_1780605234.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,405 F1 · balance_after: As of June 2, 2026, 10,047 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,379 on June 4, 2027; 2,922 on June 5, 2028 and 4,746 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:33 UTC |
Kohler Kenneth ESVP & GM, AST
|
GrantEmployee Stock Option (right to buy) · Derivative | 7,668 | $0.00 Strike: $230.74 | $0.00 |
DisclosureSEC source: 0001628280-26-040840 · wk-form4_1780605189.xml · derivative · entry 3 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,668 Underlying: Ordinary Shares · 7,668 shares Expires 2036-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 1,917 on June 2, 2027, 1,917 on June 2, 2028, 1,917 on June 4, 2029 and 1,917 on June 3, 2030. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:33 UTC |
Kohler Kenneth ESVP & GM, AST
|
Tax withholdingOrdinary Shares | 66 | $209.76 | $13,844.16 |
DisclosureSEC source: 0001628280-26-040840 · wk-form4_1780605189.xml · nonDerivative · entry 2 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,666 F2 · shares: 66 shares were withheld from the 225 restricted shares that vested on June 2, 2026. These 66 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026. F1 · balance_after: As of June 2, 2026, 5,115 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 630 on June 3, 2026; 513 on June 4, 2026; 733 on June 2, 2027; 630 on June 3, 2027; 513 on June 4, 2027; 733 on June 2, 2028; 630 on June 5, 2028 and 733 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:33 UTC |
Kohler Kenneth ESVP & GM, AST
|
GrantOrdinary Shares | 2,199 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040840 · wk-form4_1780605189.xml · nonDerivative · entry 1 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,732 F1 · balance_after: As of June 2, 2026, 5,115 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 630 on June 3, 2026; 513 on June 4, 2026; 733 on June 2, 2027; 630 on June 3, 2027; 513 on June 4, 2027; 733 on June 2, 2028; 630 on June 5, 2028 and 733 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:32 UTC |
Carestio Daniel ADirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 82,740 | $0.00 Strike: $230.74 | $0.00 |
DisclosureSEC source: 0001628280-26-040835 · wk-form4_1780605146.xml · derivative · entry 3 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,740 Underlying: Ordinary Shares · 82,740 shares Expires 2036-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 20,685 on June 2, 2027, 20,685 on June 2, 2028, 20,685 on June 4, 2029 and 20,685 on June 3, 2030. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:32 UTC |
Carestio Daniel ADirector · President and CEO
|
Tax withholdingOrdinary Shares | 995 | $209.76 | $208,711.20 |
DisclosureSEC source: 0001628280-26-040835 · wk-form4_1780605146.xml · nonDerivative · entry 2 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,583 F2 · shares: 995 shares were withheld from the 2,369 restricted shares that vested on June 2, 2026. These 995 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026. F1 · balance_after: As of June 2, 2026, 50,113 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,937 on June 3, 2026; 4,283 on June 4, 2026; 7,912 on June 2, 2027; 5,937 on June 3, 2027; 4,283 on June 4, 2027; 7,912 on June 2, 2028; 5,937 on June 5, 2028 and 7,912 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:32 UTC |
Carestio Daniel ADirector · President and CEO
|
GrantOrdinary Shares | 23,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040835 · wk-form4_1780605146.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,578 F1 · balance_after: As of June 2, 2026, 50,113 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,937 on June 3, 2026; 4,283 on June 4, 2026; 7,912 on June 2, 2027; 5,937 on June 3, 2027; 4,283 on June 4, 2027; 7,912 on June 2, 2028; 5,937 on June 5, 2028 and 7,912 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:31 UTC |
Burton Karen LSr. Vice Pres., CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 18,564 | $0.00 Strike: $230.74 | $0.00 |
DisclosureSEC source: 0001628280-26-040833 · wk-form4_1780605109.xml · derivative · entry 3 Burton Karen L · CIK 0001697095 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,564 Underlying: Ordinary Shares · 18,564 shares Expires 2036-06-02 F3 · derivative.exercise_date: This option becomes exercisable as follows: 4,641 on June 2, 2027, 4,641 on June 2, 2028, 4,641 on June 4, 2029 and 4,641 on June 3, 2030. F3 · derivative.expiration_date: This option becomes exercisable as follows: 4,641 on June 2, 2027, 4,641 on June 2, 2028, 4,641 on June 4, 2029 and 4,641 on June 3, 2030. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:31 UTC |
Burton Karen LSr. Vice Pres., CFO
|
Exercise / conversionOrdinary Shares | 66 | $209.76 | $13,844.16 |
DisclosureSEC source: 0001628280-26-040833 · wk-form4_1780605109.xml · nonDerivative · entry 2 Burton Karen L · CIK 0001697095 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: 66 shares were withheld from the 225 restricted shares that vested on June 2, 2026. These 66 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 2, 2026. F1 · balance_after: As of June 2, 2026, 10,239 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 651 on June 3, 2026; 306 on June 4, 2026; 783 on October 1, 2026; 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028 and 783 on October 1, 2028 and 1,775 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:31 UTC |
Burton Karen LSr. Vice Pres., CFO
|
GrantOrdinary Shares | 5,325 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040833 · wk-form4_1780605109.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,530 F1 · balance_after: As of June 2, 2026, 10,239 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 651 on June 3, 2026; 306 on June 4, 2026; 783 on October 1, 2026; 1,775 on June 2, 2027; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 1,775 on June 2, 2028; 651 on June 5, 2028 and 783 on October 1, 2028 and 1,775 on June 4, 2029. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:31 UTC |
Boulud PierreDirector
|
GrantCareer Restricted Stock Units · Derivative | 367 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040832 · wk-form4_1780605087.xml · derivative · entry 1 Boulud Pierre · CIK 0002134653 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 367 Underlying: Ordinary Shares · 367 shares Expires not disclosed F1 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F2 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F2 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:31 UTC |
Breeden Richard CDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,781 | $0.00 Strike: $71.40 | $0.00 |
DisclosureSEC source: 0001628280-26-040830 · wk-form4_1780605065.xml · derivative · entry 4 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,781 shares Expires 2026-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option to purchase 3,781 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,781 ordinary shares for $71.40 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:31 UTC |
Breeden Richard CDirector
|
SaleOrdinary Shares | 1,481 | $209.51 | $310,284.31 |
DisclosureSEC source: 0001628280-26-040830 · wk-form4_1780605065.xml · nonDerivative · entry 2 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,964 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $209.50 to $209.53 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 02, 2026 Filed Jun 4, 2026 20:31 UTC |
Breeden Richard CDirector
|
Exercise / conversionOrdinary Shares | 3,781 | $71.40 | $269,963.40 |
DisclosureSEC source: 0001628280-26-040830 · wk-form4_1780605065.xml · nonDerivative · entry 1 Breeden Richard C · CIK 0001300622 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:40 UTC |
Madsen JuliaSr. VP and GM, Life Sciences
|
Tax withholdingOrdinary Shares | 208 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040438 · wk-form4_1780519245.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,502 F1 · shares: 208 shares were withheld from the 578 restricted shares that vested on June 1, 2026. These 208 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 · balance_after: As of June 1, 2026, 3,425 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:40 UTC |
Fraser Mary ClareSVP & Chief HRO
|
Tax withholdingOrdinary Shares | 673 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040433 · wk-form4_1780519195.xml · nonDerivative · entry 1 Fraser Mary Clare · CIK 0001818882 · SVP & Chief HRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,209 F1 · shares: 673 shares were withheld from the 2,313 restricted shares that vested on June 1, 2026. These 673 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 · balance_after: As of June 1, 2026, 6,573 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,028 on June 2, 2026; 835 on June 3, 2026; 1,360 on June 4, 2026; 835 on June 3, 2027; 680 on June 4, 2027 and 835 on June 5, 2028. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:42 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 337 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040445 · wk-form4_1780519337.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,332 F1 · shares: 337 shares were withheld from the 1,157 restricted shares that vested on June 1, 2026. These 337 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 · balance_after: As of June 1, 2026, 7,354 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:41 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Tax withholdingOrdinary Shares | 81 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040444 · wk-form4_1780519311.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,614 F1 · shares: 81 shares were withheld from the 241 restricted shares that vested on June 1, 2026. These 81 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 · balance_after: As of June 1, 2026, 1,234 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 141 on June 2, 2026; 217 on June 3, 2026; 221 on June 4, 2026; 217 on June 3, 2027; 221 on June 4, 2027 and 217 on June 5, 2028. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:41 UTC |
McGowan LindseyVP, Chf. Comp. & Quality Offc.
|
Tax withholdingOrdinary Shares | 198 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040443 · wk-form4_1780519289.xml · nonDerivative · entry 1 McGowan Lindsey · CIK 0002102487 · VP, Chf. Comp. & Quality Offc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,830 F1 · shares: 198 shares were withheld from the 660 restricted shares that vested on June 1, 2026. These 198 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 · balance_after: As of June 1, 2026, 3,090 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,128 on June 2, 2026; 588 on June 4, 2027; 576 on June 3, 2028 and 798 on January 2, 2029. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:41 UTC |
Majors Cary LSVP and President, Healthcare
|
Tax withholdingOrdinary Shares | 768 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040440 · wk-form4_1780519265.xml · nonDerivative · entry 1 Majors Cary L · CIK 0001776271 · SVP and President, Healthcare 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,659 F1 · shares: 768 shares were withheld from the 2,697 restricted shares that vested on June 1, 2026. These 768 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 · balance_after: As of June 1, 2026, 7,441 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,140 on June 2, 2026; 2,379 on June 4, 2027 and 2,922 on June 5, 2028. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:39 UTC |
Carestio Daniel ADirector · President and CEO
|
Tax withholdingOrdinary Shares | 1,254 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040430 · wk-form4_1780519171.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,842 F1 · shares: 1,254 shares were withheld from the 4,308 restricted shares that vested on June 1, 2026. These 1,254 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 · balance_after: As of June 1, 2026, 28,746 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:40 UTC |
Kohler Kenneth ESVP & GM, AST
|
Tax withholdingOrdinary Shares | 109 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040436 · wk-form4_1780519216.xml · nonDerivative · entry 1 Kohler Kenneth E · CIK 0002010979 · SVP & GM, AST 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,533 F1 · shares: 109 shares were withheld from the 373 restricted shares that vested on June 1, 2026. These 109 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 · balance_after: As of June 1, 2026, 3,141 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 225 on June 2, 2026; 630 on June 3, 2026; 513 on June 4, 2026; 630 on June 3, 2027; 513 on June 4, 2027 and 630 on June 5, 2028. F3 · balance_after: The shares beneficially owned were erroneously reported in prior Form 4s. The shares held are being corrected in this Form 4 to reflect the current amount of shares beneficially owned. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 20:39 UTC |
Burton Karen LSr. Vice Pres., CFO
|
Tax withholdingOrdinary Shares | 99 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-040426 · wk-form4_1780519137.xml · nonDerivative · entry 1 Burton Karen L · CIK 0001697095 · Sr. Vice Pres., CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,205 F1 · shares: 99 shares were withheld from the 340 restricted shares that vested on June 1, 2026. These 99 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These vested shares were valued at the NYSE closing market price on June 1, 2026. F2 · balance_after: As of June 1, 2026, 5,139 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 225 on June 2, 2026; 651 on June 3, 2026; 306 on June 4, 2026; 783 on October 1, 2026; 651 on June 3, 2027; 306 on June 4, 2027; 783 on October 1, 2027; 651 on June 5, 2028 and 783 on October 1, 2028. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 21:32 UTC |
FELDMANN CYNTHIA LDirector
|
Exercise / conversionDirector Stock Option (right to buy) · Derivative | 3,098 | $0.00 Strike: $152.32 | $0.00 |
DisclosureSEC source: 0001628280-26-015642 · wk-form4_1772832741.xml · derivative · entry 4 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,098 shares Expires 2029-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 21:32 UTC |
FELDMANN CYNTHIA LDirector
|
SaleOrdinary Shares | 3,098 | $237.21 | $734,876.58 |
DisclosureSEC source: 0001628280-26-015642 · wk-form4_1772832741.xml · nonDerivative · entry 2 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 705 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $237.16 to $237.33 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 05, 2026 Filed Mar 6, 2026 21:32 UTC |
FELDMANN CYNTHIA LDirector
|
Exercise / conversionOrdinary Shares | 3,098 | $152.32 | $471,887.36 |
DisclosureSEC source: 0001628280-26-015642 · wk-form4_1772832741.xml · nonDerivative · entry 1 FELDMANN CYNTHIA L · CIK 0001264554 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:32 UTC |
McGowan LindseyVP, Chf. Comp. & Quality Offc.
|
GrantOrdinary Shares | 798 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-000929 · wk-form4_1767735146.xml · nonDerivative · entry 1 McGowan Lindsey · CIK 0002102487 · VP, Chf. Comp. & Quality Offc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,028 F1 · balance_after: As of January 2, 2026, 3,750 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 660 on May 31, 2026; 1,128 on June 2, 2026; 588 on June 4, 2027; 576 on June 3, 2028 and 798 on January 2, 2029. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:39 UTC |
Madsen JuliaSr. VP and GM, Life Sciences
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,136 | $0.00 Strike: $147.05 | $0.00 |
DisclosureSEC source: 0001628280-25-054011 · wk-form4_1764106761.xml · derivative · entry 6 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,136 shares Expires 2029-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:39 UTC |
Madsen JuliaSr. VP and GM, Life Sciences
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 2,872 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001628280-25-054011 · wk-form4_1764106761.xml · derivative · entry 5 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,872 shares Expires 2028-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option is fully vested. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:39 UTC |
Madsen JuliaSr. VP and GM, Life Sciences
|
SaleOrdinary Shares | 2,136 | $262.00 | $559,632.00 |
DisclosureSEC source: 0001628280-25-054011 · wk-form4_1764106761.xml · nonDerivative · entry 4 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,710 F1 · balance_after: As of November 21, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:39 UTC |
Madsen JuliaSr. VP and GM, Life Sciences
|
Exercise / conversionOrdinary Shares | 2,136 | $147.05 | $314,098.80 |
DisclosureSEC source: 0001628280-25-054011 · wk-form4_1764106761.xml · nonDerivative · entry 3 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,846 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of November 21, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:39 UTC |
Madsen JuliaSr. VP and GM, Life Sciences
|
SaleOrdinary Shares | 2,872 | $262.00 | $752,464.00 |
DisclosureSEC source: 0001628280-25-054011 · wk-form4_1764106761.xml · nonDerivative · entry 2 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,710 F1 · balance_after: As of November 21, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| November 21, 2025 Filed Nov 25, 2025 21:39 UTC |
Madsen JuliaSr. VP and GM, Life Sciences
|
Exercise / conversionOrdinary Shares | 2,872 | $114.22 | $328,039.84 |
DisclosureSEC source: 0001628280-25-054011 · wk-form4_1764106761.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,582 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of November 21, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:31 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 3,536 | $0.00 Strike: $182.22 | $0.00 |
DisclosureSEC source: 0001628280-25-053403 · wk-form4_1763674283.xml · derivative · entry 5 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,536 shares Expires 2030-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:31 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
SaleOrdinary Shares | 1,500 | $257.76 | $386,640.00 |
DisclosureSEC source: 0001628280-25-053403 · wk-form4_1763674283.xml · nonDerivative · entry 4 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,695 F1 · balance_after: As of November 18, 2025, 1,475 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 241 on June 1, 2026; 141 on June 2, 2026; 217 on June 3, 2026; 221 on June 4, 2026; 217 on June 3, 2027; 221 on June 4, 2027 and 217 on June 5, 2028. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:31 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
SaleOrdinary Shares | 212 | $258.03 | $54,702.36 |
DisclosureSEC source: 0001628280-25-053403 · wk-form4_1763674283.xml · nonDerivative · entry 3 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,195 F3 · price: Price reflects a weighted average sale price for multiple transactions ranging from $258.02 to $258.03 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: As of November 18, 2025, 1,475 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 241 on June 1, 2026; 141 on June 2, 2026; 217 on June 3, 2026; 221 on June 4, 2026; 217 on June 3, 2027; 221 on June 4, 2027 and 217 on June 5, 2028. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:31 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
SaleOrdinary Shares | 3,324 | $257.43 | $855,697.32 |
DisclosureSEC source: 0001628280-25-053403 · wk-form4_1763674283.xml · nonDerivative · entry 2 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,407 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $257.01 to $257.87 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: As of November 18, 2025, 1,475 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 241 on June 1, 2026; 141 on June 2, 2026; 217 on June 3, 2026; 221 on June 4, 2026; 217 on June 3, 2027; 221 on June 4, 2027 and 217 on June 5, 2028. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:31 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Exercise / conversionOrdinary Shares | 3,536 | $182.22 | $644,329.92 |
DisclosureSEC source: 0001628280-25-053403 · wk-form4_1763674283.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of November 18, 2025, 1,475 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 241 on June 1, 2026; 141 on June 2, 2026; 217 on June 3, 2026; 221 on June 4, 2026; 217 on June 3, 2027; 221 on June 4, 2027 and 217 on June 5, 2028. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:34 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $69.72 | $0.00 |
DisclosureSEC source: 0001628280-25-052076 · wk-form4_1763069671.xml · derivative · entry 3 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 15,000 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 15,000 ordinary shares for $69.72 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:34 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
SaleOrdinary Shares | 15,000 | $265.14 | $3,977,100.00 |
DisclosureSEC source: 0001628280-25-052076 · wk-form4_1763069671.xml · nonDerivative · entry 2 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,669 F2 · price: Price reflects a weighted average sale price for multiple transactions ranging from $265.00 to $265.95 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. F1 · balance_after: As of November 11, 2025, 8,511 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,157 on June 1, 2026; 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. Read SEC document |
| November 11, 2025 Filed Nov 13, 2025 21:34 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Exercise / conversionOrdinary Shares | 15,000 | $69.72 | $1,045,800.00 |
DisclosureSEC source: 0001628280-25-052076 · wk-form4_1763069671.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,669 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: As of November 11, 2025, 8,511 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,157 on June 1, 2026; 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. Read SEC document |
| October 06, 2025 Filed Oct 8, 2025 20:34 UTC |
Carestio Daniel ADirector · President and CEO
|
SaleOrdinary Shares | 159 | $241.82 | $38,449.38 |
DisclosureSEC source: 0001628280-25-044614 · wk-form4_1759955658.xml · nonDerivative · entry 1 Carestio Daniel A · CIK 0001651806 · Director · President and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 51,096 F1 · balance_after: As of October 6, 2025, 33,054 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,308 on June 1, 2026; 5,937 on June 3, 2026; 2,369 on June 2, 2026; 4,283 on June 4, 2026; 5,937 on June 3, 2027; 4,283 on June 4, 2027; and 5,937 on June 5, 2028. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:51 UTC |
Madsen JuliaSr. VP and GM, Life Sciences
|
Tax withholdingOrdinary Shares | 52 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-044117 · wk-form4_1759524684.xml · nonDerivative · entry 1 Madsen Julia · CIK 0001819129 · Sr. VP and GM, Life Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,710 F1 · shares: 52 shares were withheld from the 144 restricted shares that vested on October 1, 2025. These 52 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 144 ordinary shares were awarded to Ms. Madsen on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2025. F2 · balance_after: As of October 1, 2025, 4,003 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 578 on June 1, 2026, 352 on June 2, 2026; 666 on June 3, 2026; 542 on June 4, 2026; 666 on June 3, 2027; 542 on June 4, 2027 and 666 on June 5, 2028. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:50 UTC |
Fraser Mary ClareSVP & Chief HRO
|
Tax withholdingOrdinary Shares | 207 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-044116 · wk-form4_1759524651.xml · nonDerivative · entry 1 Fraser Mary Clare · CIK 0001818882 · SVP & Chief HRO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,882 F1 · shares: 207 shares were withheld from the 692 restricted shares that vested on October 1, 2025. These 201 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 692 ordinary shares were awarded to Ms. Fraser on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2025. F2 · balance_after: As of October 1, 2025, 8,886 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,313 on June 1, 2026; 2,028 on June 2, 2026; 2,040 on June 4, 2027 and 2,505 on June 5, 2028. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:53 UTC |
Zangerle John AdamSr. VP, Gen Counsel, and Sec.
|
Tax withholdingOrdinary Shares | 91 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-044120 · wk-form4_1759524783.xml · nonDerivative · entry 1 Zangerle John Adam · CIK 0001578804 · Sr. VP, Gen Counsel, and Sec. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,669 F1 · shares: 91 shares were withheld from the 202 restricted shares that vested on October 1, 2025 These 91 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 202 ordinary shares were awarded to Mr. Zangerle on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2025. F2 · balance_after: As of October 1, 2025, 8,511 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 1,157 on June 1, 2026; 846 on June 2, 2026; 1,252 on June 3, 2026; 1,376 on June 4, 2026; 1,252 on June 3 2027; 1,376 on June 4, 2027 and 1,252 on June 5, 2028. Read SEC document |
| October 01, 2025 Filed Oct 3, 2025 20:52 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
Tax withholdingOrdinary Shares | 26 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-044119 · wk-form4_1759524750.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,195 F1 · shares: 26 shares were withheld from the 86 restricted shares that vested on October 1, 2025. These 26 shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 86 ordinary shares were awarded to Mr. Tamaro on October 1, 2021. These vested shares were valued at the NYSE closing market price on October 1, 2025. F2 · balance_after: As of October 1, 2025, 1,475 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 241 on June 1, 2026; 141 on June 2, 2026; 217 on June 3, 2026; 221 on June 4, 2026; 217 on June 3, 2027; 221 on June 4, 2027 and 217 on June 5, 2028. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.